What is the CUE stock price prediction for next 2 weeks?

According to our price prediction algorithm,Cue Biopharma, Inc. (CUE) price will be around $37.43 in the next 2 weeks. This means it will increase by 21.039133247089257 from the last closing price. This prediction may vary from other time period filters for CUE stock.

What can be the highest Possible price of CUE stock in next 2 weeks?

Our forecast algorithm expects that in 2 weeks, CUE can achieve the highest price of $40.83 which is 32.06656075722691 higher than last closing price. This prediction may vary from other time period filters for CUE stock.

What can be the lowest Possible price of CUE stock in next 2 weeks?

As per the forecast and algorithmic analysis, CUE stock price can be as low as $34.24 which is 10.740713318278797 higher than the current price in the next 2 weeks. This prediction may vary from other time period filters for CUE stock.

Will CUE stock go high in the next 2 weeks?

Yes, our stock forecasting algorithm shows that CUE stock will gain21.039133247089257 in the next 2 weeks. This prediction may vary from other time period filters for CUE stock.

What is CUE stock last closing price?

Last closing price of CUE stock was $30.92.

What is CUE stock price prediction?

CUE stock price prediction means predicting the future closing prices of CUE stock based on its past data. Our forecasting algorithm uses various machine learning and deep learning techniques to forecast the future behavior of CUE stock in a certain time period.

How we predict CUE stock future prices?

If you are searching for CUE stock forecast, analysis or price prediction, then you might be wondering what Cue Biopharma, Inc. (CUE) will do in the future. Our CUE price predictions are based on various Machine Learning based algorithms with an aim to try and predict future price movements. This CUE price prediction will likely answer most of your questions.

How frequent we update CUE stock predictions?

We are updating the forecasts for the CUE stock on daily basis.

Is using ML forecasting for CUE stock a good way?

Yes. Stock Price Prediction is one of the most exciting applications of Machine Learning. By leveraging data from the past, it is possible to use forecasting models to make accurate predictions about future stock prices. This can be incredibly beneficial for investors and traders, as it gives them the ability to make more informed decisions about when to buy and sell. Investing in the stock market can be a risky endeavor, but leveraging Machine Learning can make it a bit less daunting and more profitable.

Is the Prediction for CUE stock same for all the time periods?

No, the prediction for CUE stock is not same for all time periods. The forecasts may vary depending on the differences in the time period.

Cue Biopharma, Inc. Stock Forecast and Stock Price Prediction

Stock Forecast Chart

Stock Price Prediction Summary

Closed Price$30.921.61%Since 2 Weeks

Predicted Price$37.4321.04%For 2 Weeks

Upper Predicted Price$40.8332.07%For 2 Weeks

Lower Predicted Price$34.2410.74%For 2 Weeks

Forecast Score Based on 2 Weeks

Based on our forecast, the price of CUE will rise by +21.04% over the next 2 Weeks and hit $37.43 by Monday, July 27, 2026. In that time frame, CUE's share price is expected to range between $34.24 and $40.83.

BearishAverageBullish

Date	Predicted Lower	Predicted	Predicted Upper
Jul 27, 2026	34.24	37.43	40.83
Jul 24, 2026	33.45	36.51	39.95
Jul 23, 2026	33.03	36.50	40.09
Jul 22, 2026	32.52	35.73	39.37
Jul 21, 2026	32.48	35.61	38.92
Jul 20, 2026	32.63	35.85	39.25
Jul 17, 2026	31.47	34.93	38.53
Jul 16, 2026	32.01	34.92	38.49
Jul 15, 2026	30.76	34.15	37.32
Jul 14, 2026	30.73	34.03	37.24

CUE shares fell -15.93% in Monday, July 13, 2026's trading session, dropping from a previous close of $36.78 to move at $30.92. The stock demonstrated notable intraday movement (see CUE's key stats for a full breakdown), fluctuating between $30.51 and $35.70, a +17.01% trading range. While recent weeks have seen some volatility, CUE has managed to secure a +1.61% gain over the past 2 weeks. The downward price movement was accompanied by decreased trading volume, with approximately 187.8K shares changing hands, 99.79K fewer than the previous session. This amounted to $5.81M in total market activity.

Will CUE Continue Its Upward Trend?

According to analyst ratings and projections for CUE, Cue Biopharma, Inc. shares are anticipated to increase by +24.28%, potentially reaching $40.83 per share by July 27, 2026. Short-term technical indicators for CUE currently suggest a bullish sentiment. This aligns with the stock's recent performance, as it has recorded 16 positive trading days within the past 30 sessions. Based on the CUE stock forecast, now is a good time to buy CUE stock because its current trading price is -17.38% below our predicted value, hinting at a possible overvaluation. For deeper insights, view our sentiment analysis on CUE covering social and institutional perspectives.

CUE Technical Momentum: Overbought, Oversold, or Neutral?

An analysis of Relative Strength Index (RSI) indicators provides insight into CUE's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 49.90% to 53.99%) suggest the stock is in a neutral to slightly bearish momentum phase. The 50-day RSI, at 54.96%, suggests a neutral medium-term outlook. Additionally, the 100-day RSI, at 53.59%, maintains a neutral outlook for the long term. Insights into CUE's shareholder base show how institutional investors are positioning themselves during these momentum shifts

Cue Biopharma Short-Term Forecasts

CUE Forecast For Next 5 Days

Our algorithm anticipates Cue Biopharma (CUE) stock could hit $16.36 by Jul 20, 2026. This represents a -47.08% fall from today's price, following a -13.36% change over the past five days.

CUE Forecast For Next 30 Days

Based on analysis of market trends, the outlook for Cue Biopharma, Inc. (CUE) stock over the next 30 days is largely negative. Price forecasts suggest an average target of $29.35, which would mean a -5.08% decrease from the current price of $30.92. Projections for this period range from a high of $52.05 to a low of $5.17.

CUE Forecast For Next 90 Days

Our proprietary market analysis suggests predictions for Cue Biopharma's price over the next three months point to a rise. CUE stock is expected to peak at $39.33 on Oct 06, 2026 after potentially dipping to $29.29 on Jul 20, 2026. On average, CUE is likely to trade around $33.26 in the coming 90 days.

Cue Biopharma Stock Forecast 2025

Based on our predictive models, Cue Biopharma (CUE) is expected to trade between $29.29 and $39.33 throughout 2026. This would result in an average price of $34.00, potentially offering investors a +9.96% return from current levels.

Cue Biopharma, Inc. Monthly Forecast 2026–2027

July 2026

According to our latest forecast models, Cue Biopharma, Inc. (CUE) is positioned to show a strong performance in July 2026. The price is predicted to move between $29.29 and $34.94, settling at an average of $32.14. This could translate to a +3.95% gain.

August 2026

Based on current market signals, Cue Biopharma, Inc. is projected to trend august 2026. We forecast a trading range from $29.88 to $35.41, with a likely average price of $32.75. Investors could expect a potential return of +5.92%.

September 2026

Our predictive algorithms indicate Cue Biopharma, Inc. stock may see a shift in September 2026. The expected range spans $30.00–$37.80, with an average target of $33.23. This represents a positive outlook and a possible gain of +7.47%.

October 2026

Analyzing established trends, Cue Biopharma, Inc. looks set to move in October 2026. Projections place the stock between $31.59 and $39.33, averaging around $35.65. This suggests a +15.30% gain from current levels.

November 2026

Market indicators suggest Cue Biopharma, Inc. could experience notable changes during November 2026. Prices could fluctuate within $30.34 to $38.99, with a midpoint forecast of $35.84. The stock might deliver a +15.91% gain.

December 2026

Forecasting for December 2026, models estimate that Cue Biopharma, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $29.68 and $38.59, averaging $33.72. This signals a positive trajectory with potential returns around +9.06%.

January 2027

According to our latest forecast models, Cue Biopharma, Inc. (CUE) is positioned to show a strong performance in January 2027. The price is predicted to move between $30.89 and $36.04, settling at an average of $33.45. This could translate to a +8.18% gain.

February 2027

Based on current market signals, Cue Biopharma, Inc. is projected to trend february 2027. We forecast a trading range from $30.50 to $38.36, with a likely average price of $33.93. Investors could expect a potential return of +9.73%.

March 2027

Our predictive algorithms indicate Cue Biopharma, Inc. stock may see a shift in March 2027. The expected range spans $33.11–$40.19, with an average target of $36.45. This represents a positive outlook and a possible gain of +17.88%.

April 2027

Analyzing established trends, Cue Biopharma, Inc. looks set to move in April 2027. Projections place the stock between $33.88 and $39.57, averaging around $36.67. This suggests a +18.60% gain from current levels.

May 2027

Market indicators suggest Cue Biopharma, Inc. could experience notable changes during May 2027. Prices could fluctuate within $30.48 to $39.09, with a midpoint forecast of $34.19. The stock might deliver a +10.58% gain.

June 2027

Forecasting for June 2027, models estimate that Cue Biopharma, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $31.65 and $36.89, averaging $34.14. This signals a positive trajectory with potential returns around +10.41%.

July 2027

According to our latest forecast models, Cue Biopharma, Inc. (CUE) is positioned to show a strong performance in July 2027. The price is predicted to move between $31.48 and $36.76, settling at an average of $33.98. This could translate to a +9.90% gain.

CUE's history of dividends and stock splits also plays a role in long-term investor confidence.